Cathie Wood-led Ark Invest made significant trades on Tuesday, including a noteworthy move involving Zoom Video Communications ZM and Nvidia Corporation NVDA.
The Zoom trade took center stage, with Ark Invest purchasing $8.1 million worth of Zoom shares, based on Tuesday’s closing price of $65.83. Ark Invest purchased 122,831 shares of the company through ARK Innovation ETF ARKK and ARK Next Generation Internet ETF ARKW.
This move comes on the heels of recent developments that have kept Zoom in the spotlight. The company reported a strong earnings beat in the second quarter, accompanied by robust EPS guidance and the introduction of new AI features. These announcements have contributed to renewed investor interest, driving the stock’s performance.
Additionally, Ark Invest sold $1.02 million worth of Nvidia shares on the same day, based on Tuesday’s closing price of $456.68. The trade was made through the Next Generation ETF. This decision comes amid various developments affecting Nvidia’s stock performance.
Analysts have been closely watching the company’s earnings, anticipating positive outcomes that could impact the stock’s trajectory. Expectations are that the company’s recent earnings report could have a significant impact on the stock’s trajectory, analysts anticipate that positive outcomes from the earnings release might lead to a bullish sentiment among investors. This optimism could potentially quell bearish concerns and contribute to a more favorable market outlook for Nvidia.
Other Key Trades:
- Ark Invest purchased CRISPR Therapeutics AG CRSP shares through ARK Genomic Revolution ETF ARKG.
- Significant buying activity was observed in Adaptive Biotechnologies ADPT shares through ARKG.
- Ark Invest added Recursion Pharmaceuticals RXRX shares to its portfolio through ARKG.
- Investment was made in Intellia Therapeutics Inc. NTLA shares through ARKG.
- Ark Invest sold Codexis Inc. CDXS shares through ARKG.
- Phenomex Inc. CELL shares were also sold through ARKG.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.